Back to Search
Start Over
Are we ready for long-acting HIV treatment for adolescents?
- Source :
-
The lancet. HIV [Lancet HIV] 2024 Apr; Vol. 11 (4), pp. e200-e201. - Publication Year :
- 2024
-
Abstract
- Competing Interests: NR reports grants, honoraria, consulting personal fees, and travel sponsorship from Gilead Science, Merck Sharp & Dohme, Johnson & Johnson, and ViiV Healthcare; grant support from: 1UM2HD111076-01 funded by NICHD, 1R24AI152598-0, P30AI117970, and 4R33AI142685-04 funded by NIAID, R01MH122375 funded by NIMH; and serving as a non-paid member of the Paediatric Antiretroviral Working Group at WHO.
Details
- Language :
- English
- ISSN :
- 2352-3018
- Volume :
- 11
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- The lancet. HIV
- Publication Type :
- Academic Journal
- Accession number :
- 38538156
- Full Text :
- https://doi.org/10.1016/S2352-3018(24)00039-0